BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 1691772)

  • 1. [Morphometrical and immunohistochemical analysis of cortical and medullary thymoma: its correlation with invasiveness and association with myasthenia gravis].
    Nomori H; Ishihara T; Torikata C
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jan; 38(1):93-100. PubMed ID: 1691772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological study of thymomas--correlation of histologic subtype to myasthenia gravis and prognosis.
    Sundaram C; Rajagopal P; Rakshak AD; Omprakash G; Das SM; Murthy JM
    Indian J Pathol Microbiol; 2003 Jul; 46(3):378-81. PubMed ID: 15025278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant grading of cortical and medullary differentiated thymoma by morphometric analysis.
    Nomori H; Ishihara T; Torikata C
    Cancer; 1989 Oct; 64(8):1694-9. PubMed ID: 2676138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoma--morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases.
    Quintanilla-Martinez L; Wilkins EW; Ferry JA; Harris NL
    Hum Pathol; 1993 Sep; 24(9):958-69. PubMed ID: 8253462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cortical-cell thymomas with predominance of so-called nurse-cells in patients with myasthenia].
    Zaĭrat'iants OV; Vetshev PS; Popova IV; Ippolitov IKh; Voronov LI
    Arkh Patol; 1991; 53(1):15-20. PubMed ID: 1859274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Bcl-2 protein in the myasthenic thymus.
    Onodera J; Nakamura S; Nagano I; tobita M; Yoshioka M; Takeda A; Oouchi M; Itoyama Y
    Ann Neurol; 1996 Apr; 39(4):521-8. PubMed ID: 8619530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological aspects of malignant and benign thymic disorders.
    Müller-Hermelink HK; Marx A
    Ann Med; 1999 Oct; 31 Suppl 2():5-14. PubMed ID: 10574149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
    Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
    Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between expression of Cat V and clinicopathologic character of myasthenia gravis in patients with thymoma].
    Wang Y; Huang Y; Luo DY; Yuan O; Gong RR; Qiu GD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):886-8. PubMed ID: 17236586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of E-cadherin and alpha- and beta-catenins in thymoma.
    Pan CC; Ho DM; Chen WY; Chiang H; Fahn HJ; Wang LS
    J Pathol; 1998 Feb; 184(2):207-11. PubMed ID: 9602713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticomedullary differentiation and maturational arrest in thymomas.
    Ströbel P; Hartmann E; Rosenwald A; Kalla J; Ott G; Friedel G; Schalke B; Kasahara M; Tomaru U; Marx A
    Histopathology; 2014 Mar; 64(4):557-66. PubMed ID: 24236644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymoma. Histologic subclassification is an independent prognostic factor.
    Quintanilla-Martinez L; Wilkins EW; Choi N; Efird J; Hug E; Harris NL
    Cancer; 1994 Jul; 74(2):606-17. PubMed ID: 8033040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoma--a study of 60 cases in Singapore.
    Tan PH; Sng IT
    Histopathology; 1995 Jun; 26(6):509-18. PubMed ID: 7665142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.
    Marino M; Müller-Hermelink HK
    Virchows Arch A Pathol Anat Histopathol; 1985; 407(2):119-49. PubMed ID: 3927579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopatholgical spectrum of thymic neoplasms: twelve-year experience at a referral hospital in north India.
    Radotra B; Awasthi A; Joshi K; Das A
    Indian J Pathol Microbiol; 2006 Jan; 49(1):1-6. PubMed ID: 16625962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thymoma with epithelial micronodules and lymphoid hyperplasia: six cases of a rare and equivocal subtype].
    Thomas De Montpréville V; Zemoura L; Dulmet E
    Ann Pathol; 2002 Jun; 22(3):177-82. PubMed ID: 12410100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of molecules mediating thymocyte-stroma-interactions in human thymus, thymitis and thymic epithelial tumors.
    Marx A; Schömig D; Schultz A; Gattenlöhner S; Jung A; Kirchner T; Melms A; Müller-Hermelink HK
    Thymus; 1994; 23(2):83-93. PubMed ID: 7725387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [B-cells in thymic epithelial tumors: phenotype, distribution and relation to the intramedullary B-cell population of the normal thymus].
    Fend F; Kirchner T; Marx A; Müller-Hermelink HK
    Verh Dtsch Ges Pathol; 1992; 76():253-5. PubMed ID: 1283270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.